Chylomicron physiology: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
Rim Halaby (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Chylomicron}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Chylomicrons''' are large [[lipoprotein|lipoprotein particles]] (having a diameter of 75 to 1,200[[nanometer|nm]]) that are created by the absorptive cells of the [[intestine|small intestine]].The chylomicrons are released by [[exocytosis]] from [[enterocyte]]s into [[lacteal]]s, [[lymph vessels|lymphatic vessels]] originating in the villi of the small intestine, and are then secreted into the [[bloodstream]] at the [[thoracic duct|thoracic duct's]] connection with the left [[subclavian vein]]. Chylomicrons transport exogenous [[lipid]]s to liver, [[adipose]], cardiac and skeletal muscle tissue where they are broken down by [[lipoprotein lipase]] into [[very low density lipoprotein]]s (VLDLs). | '''Chylomicrons''' are large [[lipoprotein|lipoprotein particles]] (having a diameter of 75 to 1,200[[nanometer|nm]]) that are created by the absorptive cells of the [[intestine|small intestine]].The chylomicrons are released by [[exocytosis]] from [[enterocyte]]s into [[lacteal]]s, [[lymph vessels|lymphatic vessels]] originating in the villi of the small intestine, and are then secreted into the [[bloodstream]] at the [[thoracic duct|thoracic duct's]] connection with the left [[subclavian vein]]. Chylomicrons transport exogenous [[lipid]]s to liver, [[adipose]], cardiac and skeletal muscle tissue where they are broken down by [[lipoprotein lipase]] into [[very low density lipoprotein]]s (VLDLs). | ||
== Contents when released == | == Contents when released == | ||
Latest revision as of 17:02, 12 September 2013
|
Chylomicron Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Chylomicron physiology On the Web |
|
American Roentgen Ray Society Images of Chylomicron physiology |
|
Risk calculators and risk factors for Chylomicron physiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Chylomicrons are large lipoprotein particles (having a diameter of 75 to 1,200nm) that are created by the absorptive cells of the small intestine.The chylomicrons are released by exocytosis from enterocytes into lacteals, lymphatic vessels originating in the villi of the small intestine, and are then secreted into the bloodstream at the thoracic duct's connection with the left subclavian vein. Chylomicrons transport exogenous lipids to liver, adipose, cardiac and skeletal muscle tissue where they are broken down by lipoprotein lipase into very low density lipoproteins (VLDLs).
Contents when released
Nascent chylomicrons are primarily composed of triglycerides (85%) and contain some cholesterol and cholesteryl esters. The main apolipoprotein component is apolipoprotein B-48 (APOB48).
Changes during circulation
While circulating in lymph and blood, chylomicron exchanges components with High Density Lipoproteins (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and thus matures it into a "chylomicron." APOC2 is the cofactor for lipoprotein lipase (LPL) activity. Once triglyceride stores are distributed, the chylomicron returns APOC2 (but keeps APOE) back to the HDL and thus becomes a chylomicron remnant. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.
de:Chylomikron it:Chilomicroni nl:Chylomicron fi:Kylomikroni sv:Kylomikron